Transient receptor potential vanilloid subtype 1 (TRPV1) receptor is a pain-sensing, ligand-gated, nonselective cation channel expressed in peripheral sensory neurons. Prolonged activation of TRPV1 by capsaicin leads to cell swelling and formation of membrane blebs in rat dorsal root ganglion (DRG) neurons. Similar results were obtained in NIH3T3 fibroblast cells stably expressing TRPV1. Here, we assessed the contribution of Ca 2+ and Na + ions to TRPV1-mediated changes. Cell swelling was caused by a substantial influx of extracellular Na + via TRPV1 channels, causing concomitant transport of water. In the absence of extracellular Na + , the membrane blebbing was completely inhibited, but Ca 2+ influx did not change under these conditions. stores. In the absence of extracellular Ca 2+ also the process of cell swelling was considerably slower.
Transient receptor potential vanilloid subtype 1 (TRPV1) receptor is a pain-sensing, ligand-gated, nonselective cation channel expressed in peripheral sensory neurons. Prolonged activation of TRPV1 by capsaicin leads to cell swelling and formation of membrane blebs in rat dorsal root ganglion (DRG) neurons. Similar results were obtained in NIH3T3 fibroblast cells stably expressing TRPV1. Here, we assessed the contribution of Ca 2+ and Na + ions to TRPV1-mediated changes. Cell swelling was caused by a substantial influx of extracellular Na + via TRPV1 channels, causing concomitant transport of water. In the absence of extracellular Na + , the membrane blebbing was completely inhibited, but Ca 2+ influx did not change under these conditions. ] i observed after capsaicin application is derived essentially from extracellular Ca 2+ and not from internal Ca 2+ stores. In the absence of extracellular Ca 2+ also the process of cell swelling was considerably slower.
Calretinin is a Ca 2+ buffer protein, which is expressed in a subset of TRPV1-positive neurons. Calretinin decreased the amplitude, but slowed down the decay of Ca 2+ signals evoked by ionomycin. Cells co-expressing TRPV1 and calretinin were less sensitive to TRPV1-mediated, capsaicin-induced volume increases. In TRPV1-expressing NIH3T3 cells, calretinin decreased the capsaicin-induced Ca 2+ and Na + influx. Swelling and formation of membrane blebs resulted in impaired plasma membrane integrity finally leading to cell death. Our results hint towards a mechanistic explanation for the apoptosis-independent capsaicin-evoked neuronal loss and additionally reveal a protective effect of calretinin; we propose that the Ca 2+ -buffering capacity of calretinin reduces the susceptibility of calretinin-expressing DRG neurons against cell swelling/ death caused by overstimulation of TRPV1 channels. This article is part of a Special Issue entitled:12th European Symposium on Calcium.
Introduction
Transient receptor potential vanilloid type 1 (TRPV1) is one of the main pain-sensing receptors in sensory neurons [1, 2] . TRPV1 forms a homo-tetramer with six trans-membrane segments per monomer; the N-and C-termini are intracellular. The cation pore is formed by P-loops of the four monomers and the P loop is the region between trans-membrane domains 5 and 6 [3] . When opened, both Na + and Ca 2+ ions enter the cytoplasmic compartment through TRPV1 channels localized in the plasma membrane [4] . Functionally active TRPV1 channels are also present in the ER membrane (TRPV1 ER ), depleting intracellular Ca 2+ stores upon activation [5, 6] . However, the sensitivity of TRPV1 ER to exogenous activators is lower than that of the plasma membrane-embedded TRPV1 [7] . The channel can be activated by elevated temperature (>43°C) [4] , both acidic and basic pH [8] , or by exo-and endovanilloids such as capsaicin (CAPS), resiniferatoxin (RTX) [4] , N-arachidonoyl-dopamin [9] or anandamide [10] . On the contrary, TRPV1 is blocked with the channel blocker, Ruthenium Red (RuRed) [11] and with competitive antagonists such as capsazepine [12] . In the past, TRPV1 expression was assumed to be selective for pain-sensing sensory neurons [13] . However, TRPV1 expression was detected in various organs including brain, kidney, lung, testis, pancreas, spleen, liver, stomach, skin, muscle and in cell lines derived from those [14] [15] [16] . Interestingly, TRPV1 overstimulation leading to cytotoxicity was only reported for neurons suggesting that either I) expression levels of TRPV1 in non-neuronal tissues are low, II) neurons are particularly vulnerable or III) the physiological function of the TRPV1 channel is different in various organs [17] . One caveat of the above mentioned studies is that the authors did not consider that the samples used for the identification of TRPV1 might be "contaminated" with neuronal TRPV1-positive C and
Aδ fibers that enmesh all internal organs. In addition, discordant results were obtained with two probably non-specific antibodies against TRPV1 resulting in different expression patterns, e.g. in the skin [18, 19] . In line with the above concerns, Cre-recombinase expression driven by the TRPV1 promoter was mostly restricted to peripheral neurons in transgenic mice [20] . Depending on the concentration applied and the exposure time, TRPV1 agonists cause either desensitization [21] or selective degeneration of a distinct population of primary sensory neurons involved in the mediation of pain [22] . Systemic administration of CAPS results in the death of approximately 50% of sensory neurons in rat neonates [13] and in a loss of approximately 17% in adult rats [23] . RTX, an ultrapotent CAPS analogue, almost completely eliminates TRPV1-expressing afferent neurons in adult rats, when applied systemically [24] . Thus, selective ablation of pain-sensing neurons by administration of TRPV1 agonists may be effective in chronic pain treatment [25] ; topical CAPS formulations have already been used for pain management [26] . The intrathecal administration of RTX went into a clinical trial to treat severe cancer-mediated pain [27] . However, the mechanisms by which TRPV1 agonists exert their cyto-/neuro-toxic effects are not fully understood.
Calretinin (CR) is a cytosolic Ca 2+ buffer protein from the large family of EF-hand proteins, characterized by fast Ca 2+ -binding kinetics [28] and may have additional functions, possibly as a Ca 2+ sensor [29] . CR is expressed in specific populations of neurons in the central and peripheral nervous systems [30] and in certain cancer cells [31, 32] . In neurons, CR was proposed to be implicated in neuroprotection. CR-expressing cortical neurons are selectively resistant to excitotoxicity in vitro [33] and ectopic CR expression delays the onset of cell death in glutamate-sensitive P19 cells [34] and protects N18-RE105 neuroblastoma-retina cells from glutamate-induced excitotoxicity [35] . In this study, we set out to investigate whether CR also has a protective effect against CAPS-induced, TRPV1-mediated "neurotoxicity." Beforehand we elaborated on the mechanisms of CAPS-induced cell death in an in vitro model system using TRPV1-expressing fibroblasts (NIH3T3). Activation of the TRPV1 channel led to entry of Ca 2+ and mostly Na + , the latter causing water influx and associated volume increase in TRPV1-expresing cells. The rapid volume increase caused a proportion of cells to lose plasma membrane integrity and to die by a necrotic, caspase-3/7-independent mechanism. Entry of Ca 2+ via plasma membrane TRPV1 channels increased the effect on volume increase and cell death and the presence of CR attenuated the CAPS-mediated effects and consequently prevented/delayed cell death.
Materials and methods

Reagents
Thapsigargin, ionomycin (IONO), N-methyl-D-glucamine (NMDG) and rat nerve growth factor were purchased from Sigma Aldrich (St. Louis, MO, USA). Capsaicin (CAPS) and Ruthenium Red (RuRed) were purchased from Tocris Bioscience (Bristol, UK). Fluo-3-AM, FuraRed-AM, calcein-AM, CoroNa-Green-AM and pluronic acid were from Invitrogen (Carlsbad, CA, USA).
Cell cultures and plasmids
NIH3T3 cells were grown in RPMI 1640 medium (Invitrogen) supplemented with 10% fetal calf serum, 100 U/ml penicillinstreptomycin (PEN-STREP). TRPV1-expressing NIH3T3 cells were a kind gift from Dr. Zoltan Olah, Szeged, BRC. In those cells, the metallothionein promoter is used to drive the expression of fulllength rat TRPV1 with a short 12 amino acid ε-tag [5] . This promoter is slightly leaky. Without any induction, it provides a stable, permanent expression of TRPV1 protein [5] . All cultures were maintained in a humidified atmosphere at 37°C and 5% CO 2 . For the generation of a NIH3T3 and TRPV1/NIH3T3 cell line stably expressing a fusion protein termed eGFP-CR consisting of the enhanced green fluorescent protein (eGFP) as the N-terminal part and full-length human calretinin as the C-terminal part, the retroviral expression vector pLVTHM (Addgene plasmid 12247 [36] ) was used. The GFP cassette in pLVTHM was replaced with the eGFP-CR cDNA (B. Schwaller and J. Antonov, unpublished). Briefly, the eGFP-CR insert was synthesized by PCR using the primers PmeIeGFP (5′-GTTTAAACCGCCACCATGGTGAGCAAGGGC-3′) and SpeI-CR (5′-ACTAGTTTACATGGGGGGCTCGCTGCA3′) using the plasmid pEGFP-CR as template. The PCR fragment was subcloned into pGEM-T-easy (Promega). pGEM-T-easy was digested with PmeI and SpeI and the PCR amplicon inserted into the unique sites of the pLVTHM to produce the final pLVTH-eGFP-CR. The CMV-mRFP-CR plasmid coding for the monomeric red fluorescent protein (mRFP) was produced by inserting the CR sequence into the pDsRed-Monomer-C1 plasmid (Clontech, Mountain View, CA). Briefly, HindIII and KpnI restriction endonuclease sites were incorporated into the CR PCR fragment amplified from pRSV-CR [34] using the forward 5′-GAGAAAGCTTTAGCTGGCCCGCAG CAGC-3′ and reverse 5′-GAGAGGTACCTTACATGGGGGGCTCGCTGCA-3′ primers, respectively. After digesting the PCR fragment with these enzymes, the size-separated DNA insert was ligated in pDsRedMonomer-C1 at the compatible HindIII and KpnI sites. The mRFP-CRexpressing NIH3T3 cells were generated by transient transfection using the TransIT®-2020 transfection reagent (Mirus Bio, Madison, WI, USA) following the manufacturer's instructions. All plasmids were verified by DNA sequencing. Lentivirus was produced by the calcium phosphate transfection method using HEK293T cells and three plasmids: expression plasmid (pLVTHM-eGFP-CR), envelope plasmid pMD2G-VSVG (Addgene plasmid 12259) and packaging plasmid (pCMV-dR8.91), a kind gift from Prof. D. Trono (EPFL, Lausanne). Viral supernatants were collected after 48 h and 72 h, filtered, aliquoted and frozen at −80°C [37] . After infection of NIH3T3, HeLa or TRPV1/ NIH3T3 cells, clones showing high fluorescence intensity, i.e. high protein expression levels, were selected for further experiments.
Primary DRG cultures
DRG primary cultures were prepared from embryonic rats (E15). Embryos were removed from the uterus and placed in Petri dishes containing Krebs-Ringer buffer (in mM: 119 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1.2. MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , 2 glucose; pH 7.4). The cords were dissected and DRGs were removed. The tissue was digested in 0.05% trypsin at 37°C for 10 min and dissociated cell cultures were maintained in DMEM containing 5% horse serum and 100 ng/ml nerve growth factor to promote neuronal survival and differentiation. After 2 days in vitro (DIV2) primary DRG cultures were analyzed using confocal microscopy (Leica TCS SP5).
Cobalt histochemistry
CAPS-induced activation of plasmalemmal TRPV1 was assessed by cobalt uptake. Cells seeded on glass coverslips at approximately 50% confluence were washed with physiological salt solution (0.9% NaCl) and then incubated for 10 min in the same solution containing 5 mM CoCl 2 and one of the following substances: 1) no additive (control); 2) CAPS (5 μM); 3) IONO (5 μM); 4) CAPS (5 μM) and Ruthenium Red (20 μM). Cells were washed 3-times with physiological salt solution. Cobalt taken up by activated TRPV1 channels was precipitated by adding a 2.5% β-mercaptoethanol solution in physiological salt solution for 5 min. Cells were fixed in 4% paraformaldehyde solution and mounted. Pictures from the slides with cobalt precipitate were taken with a light microscope DM RBE (Leica, Wetzlar, Germany).
Calcium imaging
Cells grown on collagen-coated glass bottom 35 Fluorescence intensity values were normalized in each experiment to the averaged basal value measured during the non-treated period. Bleaching correction was carried out, when the baseline was not stable. The LAS-AF (Leica) and Prism3 (GraphPad Software, Inc., San Diego, CA) software were used for data analysis.
Cell volume estimation
Cell volumes were measured using two methods: the image analysis [38] and fluorescence analysis [39] methods. The image analysis technique allows to following the changes, both in the cell morphology and [Ca 2+ ] i . In this case the transmitted images were evaluated. Cell borders were traced on the monitor with the use of the mouse. The surface area of traced regions was determined by the image analysis software ImageJ. The relative cell volume changes were determined by the following relationship:
where V(t) is the cell volume at time point t; V(0) is the cell volume before treatment; S(t) is the surface area at time point t; S(0) is the surface area before treatment.
The fluorescence cell volume measurement is based on the dilution of the dye calcein. Calcein is a fluorescent dye that is not sensitive to the changes in either [Ca 2+ ] i or [Na + ] i at physiological pH. Cells were loaded with 2 μM calcein-AM in cell medium at 37°C for 30 min. Excitation was performed at 488 nm, and the emitted fluorescence was measured at 517 nm. The relative cell volume changes were determined by the following equation:
where V(t) is the cell volume at time point t; V(0) is the cell volume before treatment; F(t) is the fluorescence intensity of calcein at time point t: F(0) is fluorescence intensity of calcein before treatment; C(t) is the calcein concentration at time point t, C(0) is the calcein concentration before treatment. A comparison of two methods for measuring cell volume revealed no significant difference between the two.
Immunohistochemistry
Mice were anesthetized with pentobarbital (0.5 ml/kg i.p.; Eutha 77®; Essex Pharma GmbH, München) and then transcardially perfused with physiological salt solution followed by 4% paraformaldehyde (pH 7.4). The lumbal DRGs and TGs were quickly removed, postfixed with paraformaldehyde, cryoprotected in 30% sucrose, embedded in OCT compound (Ted Pella, Inc., Redding, CA), frozen, and sectioned on a Microm HM550 cryostat (Zeiss, Oberkochen, Germany). Sections of 10-μm thickness were cut and mounted on SuperFrost glass slides (Thermo Fisher Scientific, Waltham, MA). TG and DRG sections were circled with a water-resistant pen (DakoCytomation A/S, Glostrup, Denmark) and pre-treated with a blocking solution of 0.1% Triton X-100 and 1% donkey serum (Sigma-Aldrich) in PBS for 1 h. Then slides were co-incubated with a mix of rabbit anti-mouse TRPV1 antibody (1:1000, Genetex, San Antonio, USA) and goat anti-CR antibody CG1 (1:300, SWant, Bellinzona) in PBS overnight at 4°C. After washing with PBS, sections were incubated with Cy3-conjugated donkey anti-rabbit IgG (1:500, Jackson, USA) and Alexa-488-conjugated donkey anti-goat IgG (1:2000, Jackson) for 2 h at 37°C. Slides were counterstained with 10 μg/ml DAPI (Invitrogen) in Tris-buffered saline for 10 min, and mounted with Hydromount solution (National Diagnostics, Atlanta, GA). Stained slides were photographed using a confocal microscope DMI6000 integrated to a TCS-SP5 workstation (Leica).
Western blotting
Protein samples were isolated from either cell lysates, rat or mouse tissue. Freshly excised rat or mouse trigeminal ganglia (TG) or dorsal root ganglia (DRG) were frozen in liquid nitrogen and homogenized in extraction buffer (10 mM Tris, pH 7.4, 2 mM EDTA, 1 mM β-mercaptoethanol) containing a cocktail of different protease inhibitors (Roche, Mannheim, Germany). Extraction buffer was also added to the trypsinized cells and then the soluble proteins were extracted by ultrasonication for 3×20 s. The suspension was centrifuged (12,000g, 4°C, 20 min). Protein concentration in the supernatant was determined with the Bradford protein assay (Bio-Rad, Hercules, CA). Protein (0.3 μg) from each cell culture sample, 10 μg protein from TG and DRG, as well as 200 ng of purified CR were loaded on SDS-polyacrylamide gels (10%). After separation, proteins were transferred onto nitrocellulose membranes. After blocking with 5% fat milk powder the nitrocellulose membrane was treated overnight with rabbit anti-CR primary antibody diluted at 1:10,000. Appropriate secondary antibodies linked to horseradish peroxidase (Sigma-Aldrich) were diluted at 1:10,000. For the detection, a chemiluminescent reagent Luminata Classico Substrate (EMD Millipore Corporation, Billerica, MA, USA) was used. Chemiluminescent and normal illumination digital images were recorded on a system from Cell Biosciences (Santa. Clara, CA, USA).
Membrane integrity measurements
Cells were seeded on 24-well plates at 50% confluence. Cells were incubated in one of the following solutions: 1) DPBS; 2) DPBS with CAPS (5 μM); 3) low Ca 2+ solution with CAPS (10 μM) and EDTA (10 μM); 4) NMDG solution and CAPS (10 μM); 5) DPBS+CAPS (10 μM)+ RuRed (10 μM). After 90 min, cells were incubated with 1 μM propidium iodide (necrotic cell marker) and 1 μM Hoechst33342 to label all nuclei for 30 min. Pictures were taken with a Leica DMI 6000B fluorescence microscope. Cells with red and blue nuclei were counted and the ratio red/blue was calculated.
Cytotoxicity and caspases-3/7 activity measurements.
The ApoTox-Glo™ Triplex assay (Promega, Madison, WI, USA) was used to measure the activity of dead cell proteases and caspase-3/7 enzymes. TRPV1/NIH3T3 cells were seeded in black and white 96-well plates (Thermo Scientific, Roskilde, Denmark) at a density of 10,000 cells/well. After 2 and 4 h of CAPS exposure, the reagents were added and cells incubated for 30 min. The luminescence and the fluorescent intensity (at 485 nm excitation and 535 nm emission) were monitored with a Victor X3 2030 Multilabel Reader (Perkin Elmer, Waltham, Massachusetts). (60 kDa) in the sample of recombinant human CR used as a standard is a dimer resulting from long storage of purified CR as described before for other CaBPs [32] .
Results and discussion
CR is expressed in a subset of TRPV1-positive DRG and TG neurons
We first investigated the expression of CR in peripheral nerve cells, in particular in dorsal root ganglion (DRG) and trigeminal (TG) neurons. In the mouse TG, CR-immunoreactive (CR-ir) neurons were of predominantly large and medium body size (~20% of the total neurons), while TRPV1-ir neurons were mainly small or medium-sized neurons (~35% of total neurons); double labeling was relatively rare and was observed in approximately 6% of neurons. About 27% of CR-ir neurons were also immunoreactive for TRPV1 and 18% of the TRPV1-ir neurons showed CR expression (Fig. 1A and B) . The relative distribution of the 2 proteins in the DRG was similar; about 36% of CR-ir neurons co-expressed TRPV1 protein and 24% of the TRPV1-ir showed CR expression ( Fig. 1A and B) . Qualitatively similar immunohistochemistry results were also observed in rat TG and DRG neurons (data not shown). In mouse and also rat TG and DRG tissue, CR was expressed as evidenced by Western blot analysis (Fig. 1C) . A protein band of approx. 30 kDa co-migrating with recombinant human CR was present in all samples. The weaker CR bands in mice tissue might have two reasons: I) excision of DRG and TG tissue in rat is more precise, thus less dilution by CR-negative surrounding tissue and II) CR expression levels in rat DRG and TG neurons might be higher than in mouse neurons.
The presence of CR in a sub-population of pain-sensing neurons has been reported before [40, 41] ; nociceptors-expressing neurons were identified by the presence of pain-related peptides, tachykinins. In the rat DRG, 7.2% of CR-ir neurons were tachykinin-ir and in the TG, a larger proportion of CR-ir cells (38.4%) showed tachykinin expression [41] . In this study, we identified the pain-sensitive neurons by TRPV1 immunohistochemistry. The distribution pattern of CR and TRPV1 in sensory ganglions was rather similar. This is not surprising, considering that TRPV1 strongly co-localizes with tachykinins, such as substance P [42] or with the tachykinin receptor NK1 [43] . ] i levels remained elevated until the end of the recording period ( Fig. 2A and B) . These cells correspond to the TRPV1-ir neurons as previously confirmed by others [4] CAPS-responsive cells also showed morphological changes. Some neurons became appreciably swollen, retracted their axons and then "exploded," i.e. losing the membrane integrity ( Fig. 2A) . Along some neuronal processes, membrane blebs appeared suggesting that actin attachment sites between the plasma membrane and the underlying cytoskeleton may be weakened by CAPS treatment ( Fig. 2A) . At least two types of membrane blebs occurring during biological processes including cell movement, viral infections, cell division and cell death have been described [44] . The first one called "apoptotic blebs" is seen during apoptosis, cell division or cell movement; blebs are small, short-lived (few minutes) and they can retract. In contrast, necrotic blebs are large and translucent; their size increases over long periods of time, they cannot retract [44] , are independent of actomyosin contraction [45] and their growing is based on the influx of ions and water [39] . Although CAPS-induced blebs along DRG neuron processes were small, they did not retract and grew continuously during the observation period indicative of necrotic blebs. In rat DRG neurons, similar findings were reported before, e.g. after RTX administration, [46] and in mouse neocortical neurons upon NMDAreceptor (over)activation [47] .
Effects of CAPS on cultured DRG neurons
Effects of CAPS on TRPV1-expressing NIH3T3 cells
To get a better mechanistic insight into the processes leading to the observed CAPS-induced, likely TRPV1-mediated changes in DRG neurons, we used as a model NIH3T3 cells with or without TRPV1 expression, thus allowing to selectively investigate the role of TRPV1. While TRPV1/NIH3T3 cells exposed to CAPS (5 μM) showed a rapid increase in [Ca 2+ ] i that persisted during the recording period of 15 min, control NIH3T3 did not respond to CAPS application ( Fig. 3A  and B ] i levels later on were more variable, but on average stayed around values reached shortly (b 2 min) after CAPS application (Fig. 3B) . Resulting from CAPS application, cell roundening and swelling, as well as the appearance of membrane blebs was evident selectively in TRPV1/NIH3T3 cells (Fig. 3A) . Cell swelling was quantitatively analyzed: a constant increase in cell volume reaching approximately 200% after 10 min was observed (Fig. 3C) . The morphology of NIH3T3 control cells was indistinguishable from untreated cells (data not shown). Thus, in all further experiments, NIH3T3 cells were used as a negative control, although a small CAPS-dependent increase of [Ca 2+ ] i in a subclone of NIH3T3 cells has been reported before [48] . In our hands NIH3T3 cells were non-responsive to CAPS treatment. Blocking of the functional TRPV1 channels in the plasma membrane by the membrane-impermeant RuRed inhibited cell swelling (Fig. 3C) ] i after CAPS application in the presence of RuRed did not cause the cells to swell, i.e. to increase their volume (Fig. 3C) . As the TRPV1/NIH3T3 cells showed similar morphological and intracellular [Ca 2+ ] i changes in response to CAPS application compared with the cultured DRG primary neurons, we used TRPV1/NIH3T3 cells for further experiments aimed to delineate the CAPS-induced mechanisms leading to swelling and cell death.
In cortical neurons, bleb formation, more precisely an increase in the size of varicosities was suggested to be caused by NMDA receptor activation leading to accumulation of excess [ [46] . A crucial role of Na + influx in bleb formation on inner hair cells appearing during the isolation process of the organ of Corti was shown [51] and in hepatocytes, cell swelling evoked by free-radical exposure was attenuated in cells, whose Na + pump was inhibited with ouabain [52] . Finally, blocking a non-identified non-selective cation channel by flufenamic acid, inhibiting stretch-activated cation channels by Gd 3+ or replacement of extracellular Na + with NMDG was also effective against free-radical induced necrosis in hepatocytes [39] . Thus, in the next series of experiments we investigated the effect of Na + ions on CAPS-mediated cell morphology alterations.
Na + influx through the TRPV1 channel
The TRPV1 channel is a non-specific cation channel permeable for Ca 2+ ions, but also for Na + ions [4] . ] i remained unchanged (Fig. 4C) . The increase in [Na + ] i in the extracellular solution evoked morphological changes; mainly membrane bleb formation rather than cell swelling (Fig. 4B) .
In a previous study it was concluded that increased [ ] i to basal levels might take much longer for CAPS-treated TRPV1-expressing HEK293 [54] or NIH3T3 cells (our study). We did not determine how long it would take for [Na + ] i to reach basal levels after CAPS removal in TRPV1/NIH3T3 cells. However, also in neurons recovery from increased [Na + ] i is rather slow, in parallel to the rather long periods required for the retraction of transient membrane blebs. In cortical neurons it takes 2 h to revert blebs after removal of the glutamate receptor agonist NMDA [47] . Also neuronal cell swelling caused by veratridine, an activator of a voltage-gated Na + channels persisted for 90 min after drug removal [38] .
Increasing [Ca
2+
] o promotes Na + influx through TRPV1 channel
In the next series of experiments, we investigated the role of [Ca 2+ ] o on the CAPS-mediated effects. In the absence of extracellular [Ca 2+ ] o cell swelling (volume increase) was much slower and also the magnitude was much smaller 10 min after CAPS application (Fig. 5A ) in comparison to [Ca 2+ ] o of 1 mM depicted in Fig. 3C . The small increase in [Ca 2+ ] i resulting from TRPV1 ER -mediated ER Ca 2+ release was of similar magnitude as observed after blocking of plasma membrane TRPV1 by RuRed (Fig. 3B ). Increasing [Ca 2+ ] o to 0.5 mM resulted in a rapid increase in [Ca 2+ ] i (Fig. 5B ) and concomitantly to an increase in cell volume (Fig. 5A) ] i in membrane bleb formation was previously provided in experiments using the TRPV1 agonists CAPS and the more potent RTX. In DRG neurons, the latter caused a six-fold higher membrane loss (bleb formation) compared to CAPS; this increase was due to longer lasting elevations in [Ca 2+ ] i in the presence of RTX, while the maximum increase in [Ca 2+ ] i evoked by short RTX treatment was not different from the one induced by CAPS [6] . Thus, the authors concluded that "the prolonged elevations in [Ca 2+ ] i may potentiate RTXs toxicity." Ionic currents through TRPV1 channels are different at higher [Ca 2+ ] o : the reduction in the ratio of Ca 2+ and Na + ion permeability (P Ca /P Na ) is the consequence of prolonged activation of TRPV1 channels, which causes activation-evoked modifications in the TRPV1 pore structure [55] . At low [Ca 2+ ] o , TRPV1 channels show a time-dependent increase in the P Ca /P Na ratio. ] i was the likely result from increased Ca 2+ extrusion and/or organellar Ca 2+ uptake, because no changes in membrane integrity evidenced by propidium iodide exclusion were observed (data not shown).
In TRPV1-expressing NIH3T3 we could distinguish two cell subpopulations based on their response to IONO. In the first population (p1), IONO caused a single Ca 2+ peak similar to that seen in control NIH3T3 cells (Fig. 6B) . In p1 cells CAPS administration 4 min after IONO treatment evoked a second, robust [Ca 2+ ] i increase (Fig. 6B ).
In the second population (p2), [Ca 2+ ] i remained elevated after IONO treatment and the sequential CAPS administration resulted in an additional, but rather minor increase in [Ca 2+ ] i (Fig. 6B) . The proportion of the p2 subpopulation ranged from 24% to 55% in individual experiments. A likely explanation for the different effects seen in p1 and p2 cells is possibly linked to different TRPV1 expression levels and/or IONO sensitivity. We hypothesize that only in p2 cells IONO-induced elevations in [Ca 2+ ] i were sufficient for robust TRPV1 activation and thus addition of CAPS had a minor additional effect. Upon IONO treatment membrane ] i is required and sufficient to activate TRPV1 channels that led to an increase in cell volume and bleb formation (Fig. 6A) .
The above results were further validated in control NIH3T3 and TRPV1/NIH3T3cells by cobalt accumulation experiments. Treatment with CAPS (5 μM) or IONO (5 μM) resulted in a robust or minor cobalt accumulation in TRPV1/NIH3T3 cells, respectively (Fig. 6C) . The CAPSinduced precipitate could be prevented by RuRed (not shown). In the absence of CAPS or IONO, but incubation with the cobalt solution, TRPV1/NIH3T3 cells showed no brownish cobalt precipitate (Fig. 6C) . In control NIH3T3 cells, the addition of CAPS and IONO did not result in cobalt accumulation (Fig. 6C) .
A similar effect has been previously reported in DRG neurons: the CAPS-mediated increase in [Ca 2+ ] i was about twofold larger when CAPS was added shortly after addition of thapsigargin, [6] and also Ca 2+ mobilization by carbachol led to TRPV1 activation [58] . We hy- Since CR is expressed in a sub-population of TRPV1-ir neurons, the role of CR in CAPS-mediated cell morphology changes was analyzed in the NIH3T3 model system using control NIH3T3 cells, TRPV1/ NIH3T3 cells and additionally in HeLa cells, all of which showed no endogenous CR expression evidenced by Western blot analysis (Fig. 1C) . In order to directly assess relative CR expression levels we used constructs coding for fusion proteins consisting of either eGFP or mRFP as the N-terminal part followed by full-length CR as the C-terminal part. Stably eGFP-CR expressing clones were established by lentivirus infection of the above cell lines, followed by cloning by limiting dilution. Testing of CR protein expression in selected clones revealed the clones to contain considerable amounts of CR (Fig. 1C) . Sufficiently high CR expression levels were considered as a requirement in order to detect changes in CR-expressing and non-expressing clones, since also ] i within the first 30 s after CAPS administration was slower in CR-expressing cells. Moreover, the maximal value during the plateau phase remained always lower in eGFP-CR/TRPV1/NIH3T3 cells than in TRPV1/NIH3T3 cells without CR expression (Fig. 7B) . In parallel, the increase in volume was clearly smaller in the CR-expressing cells (Fig. 7C ) and also bleb formation was less pronounced (data not shown). Along the same line, also the CAPS-induced increase in [Na + ] i in cells expressing mRFP-CR was significantly lower just shortly after CAPS application, at later time points (>1 min after CAPS treatment) these difference disappeared (Fig. 7D) . Nonetheless, the CR-provoked decrease in cell volume persisted for at least 15 min (Fig. 7C) ] i . However, we cannot exclude the possibility that CR might also modulate TRPV1 activity via an interaction with other proteins affecting TRPV1 channel function or directly with the TRPV1 channel. We have summarized the molecular mechanisms underlying the cell swelling caused by prolonged TRPV1 activation in the scheme shown in Fig. 8 . overload has been demonstrated in several systems. Calretininexpressing neurons were relatively spared after exposure to either NMDA, glutamate or Ca 2+ ionophore [33] . The expression of calretinin also protected N18-RE 105 neuroblastoma-retina hybrid N18 cells against excitotoxic cell death [35] . Calretinin delayed the onset of cell death after excitotoxic stimulation in transfected P19 cells [34] . In Huntington's disease, where the excitotoxic effect of glutamatergic striatal inputs originating from the thalamus and cerebral cortex might play a role in disease progression, the calretinin-positive interneurons were preferentially spared [61] .
Prominent Na + influx contributes to CAPS-induced TRPV1-mediated cell death
To demonstrate that the fast cell-killing effects of high doses (10 μM) of CAPS is based on its ability to induce efficient and prominent Na + and water influx with which TRPV1-expressing NIH3T3 cells cannot cope, we measured the cell membrane integrity under different conditions. In TRPV1/NIH3T3 cells CAPS-treated under control conditions, approximately 50% cells stained positive for propidium iodide (PI) (Fig. 9A) . A significant decrease in the proportion of impaired (PI-positive) cells was encountered in the presence of RuRed or the absence of either Ca 2+ or Na + ions in the extracellular medium. Moreover, cells expressing calretinin were also protected to the same degree as cells treated with the TRPV1 inhibitor RuRed or cells subjected to CAPS treatment in the absence of extracellular Ca
2+
or Na + ions. NIH3T3 cells without TRPV1 expression were not sensitive to CAPS-induced cytotoxicity (Fig. 9A) . Finally, we investigated the mechanism leading to CAPS-mediated cytotoxicity by simultaneously analyzing the activity of dead cell proteases, markers for necrotic cell death and caspase-3/7, markers for apoptosis. Based on the previous experiments, we hypothesized a CAPS-induced mostly necrosis-like process. Two and four hours of CAPS treatment resulted in concentration-dependent increase in markers of necrosis, while no evidence for caspase-3/7 activation, a marker for the intrinsic apoptosis pathway, was observed (Fig. 9B) .
Acute cytotoxicity was seen only at higher CAPS concentrations, 5 and 50 μM.
The cellular and molecular mechanisms underlying the CAPSinduced neural loss are still unresolved. Evidences for CAPS-induced neuronal cell death by apoptosis with caspase activation have been reported [62, 63] , while some studies state that it is an apoptosislike, but caspase-independent process [64, 65] . Yet other studies doubt the process to be apoptosis at all [5, 46] . It is very likely that several mechanisms might play a role in TRPV1-mediated toxicity also depending on the cell type and moreover on the experimental protocol.
An essential role for Ca 2+ ions in the extracellular milieu for CAPS-induced cytotoxicity has been reported before [54] and was also confirmed in our study. Moreover, we demonstrated the pivotal role of Na + influx; our data show that CAPS treatment for 2-4 h causes a loss of membrane integrity typical for necrosis loss due to prominent Na + and water influx (Fig. 8) . We suggest that this mainly occurred in those cells, where the TRPV1 surface density is high. This might then be followed by an apoptotic process, in which the continuously elevated [Ca 2+ ] i and possibly the resulting mitochondrial Ca 2+ overload might trigger the apoptotic events as shown before [66] . When CAPS is applied at very high, millimolar concentrations, it can cause TRPV1-independent cell death [67] . Under these conditions CAPS replacing quinone in the mitochondrial respiratory chain inhibits energy production that finally leads to apoptosis. However, this was certainly not the case in our study, where in most experiments 5 μM CAPS was used. ing to a TRPV1-modulating protein or directly to TRPV1 channels remains to be determined. Positive modulation of TRPV1 is marked by "+," negative modulation/ inhibition by "−." Solid arrows show experimentally proven regulation and the dashed arrow indicates hypothetical modulation of TRPV1 (e.g. by CR). Data are mean ± SD. B. CAPS treatment of TRPV1/NIH3T3 cells for 2 and 4 h results in a dose-dependent increase in cytotoxicity (necrosis) with no caspase-3/7 (apoptosis) activation. The experiment was repeated two times.
Outlook
Considering that CR and TRPV1 co-expressing neurons are mainly medium size Aδ-type neurons, which are involved in fast-pain transmission, we may speculate that these neurons are much more resistant to Ca 2+ and Na + overload induced by repetitive activation of TRPV1 than the small mainly unmyelinated C-neurons, which are associated with chronic, dull pain. The membrane bleb formation of C-fibers could explain the reversible reduction in intra-epidermal nerve fibers observed after 8% CAPS patch application [26] . The significant volume increase in sensory axons may result in severing/fragmentation or retraction of axons. This phenomenon we also observed in vitro on DRG axons and on the long protrusions of fibroblast cells. Comparing the effect of RTX and CAPS in different experiments [68] , it was reported that although RTX binds 100,000-fold more effectively to TRPV1 than CAPS [69] , the pungency test showed only a difference by a factor of 10 [70] . We may hypothesize that the RTX-evoked pain sensation and pain transmission is "reduced," by the fragmentation/severing of sensory axons due to the more pronounced membrane loss [46] .
The similarities between the TRPV1-mediated neurotoxicity and the glutamate-receptor-mediated excitotoxicity are conspicuous. In both cases, ligand-gated channels form a pore for Ca 2+ and Na + ions. The permeability of TRPV1 to Ca 2+ and Na + (P Ca /P Na = 9.6) [4] is similar to values reported for NMDA glutamate receptors (P Ca /P Na =10.6) [71] . The glutamate receptor activation by NDMA also causes membrane bleb formation in cortical neurons [47] and Na + ions have already been proposed to be involved in neuronal cell death caused by glutamate receptor agonists [72, 73] . Loss of pain-sensing neurons by TRPV1-mediated overstimulation is usually not a life-threatening situation, but loss of other neuron populations by excitotoxicity, e.g. motor neurons or cortical neurons, can cause severe conditions [74] . Because cell volume regulation is a critical step in both processes, a better understanding of the mechanisms of bleb formation might lead to identifying the steps involved in the development of excito-/neurotoxicity-related diseases.
